Evidence map›Paper›PMID 41503792›Full record

ArticleChemistry & biodiversity2026

Lindenane Sesquiterpenoid Hetero- or Homo-Dimers From Sarcandra glabra and Their Anti-Neuroinflammatory Activities.

Jin-Yu Li, Yuan-Yuan Liu, Dong-Yu Wang, Han-Fei Liu, Chao Chen, Ni Zhang

Abstract read
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jin-Yu LiState Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Guizhou Medical University, Natural Products Research Center of Guizhou Province, Guiyang, P. R. China.ORCID https://orcid.org/0000-0002-5036-8730
Yuan-Yuan LiuState Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Guizhou Medical University, Natural Products Research Center of Guizhou Province, Guiyang, P. R. China.
Dong-Yu WangState Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Guizhou Medical University, Natural Products Research Center of Guizhou Province, Guiyang, P. R. China.
Han-Fei LiuState Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Guizhou Medical University, Natural Products Research Center of Guizhou Province, Guiyang, P. R. China.
Chao ChenState Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Guizhou Medical University, Natural Products Research Center of Guizhou Province, Guiyang, P. R. China.
Ni ZhangState Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Guizhou Medical University, Natural Products Research Center of Guizhou Province, Guiyang, P. R. China.

Funding

Doctoral start-up funding TCZJZ[2025]8HNatural Science Foundation of China 32160102Natural Science Foundation of China 32460112State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University GMUSKL-202536Traditional Chinese Medicine and Ethnic Medicine Science and Technology Projects of Guizhou Administration of Traditional Chinese Medicine QZYY-2025-064Traditional Chinese Medicine and Ethnic Medicine Science and Technology Projects of Guizhou Administration of Traditional Chinese Medicine QZYY-2025-081
6 · The paper itself

Abstract

Eighteen lindenane sesquiterpenoid dimers, including three previously undescribed hetero- or homo-dimers (1-3), were isolated from the whole plant of Sarcandra glabra. Their structures were elucidated by High-resolution electrospray ionization mass spectrometry, one- and two-dimensional nuclear magnetic resonance, quantum chemical calculations, and electronic circular dichroism calculations. Notably, compound 1 is a rare hetero-dimer formed by [4 + 2] cycloaddition of a eudesmane and a lindenane sesquiterpene, via C-15-C-9', C-6-C-8', and C-11-C-7' linkages. Compound 2 features a unique epoxide structural motif. All compounds were evaluated for their inhibitory effect on nitric oxide (NO) production induced by lipopolysaccharide (LPS) in BV-2 cells. The inhibitory effects of all isolates on LPS-induced NO production in BV-2 cells were evaluated. Thirteen compounds, excluding 3, 5, 13, 15, and 16, exhibited IC

Indexed as

Anti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalSesquiterpenesAnimalsCell LineCyclooxygenase 2DimerizationDose-Response Relationship, DrugLipopolysaccharidesMiceMolecular StructureNitric OxideStructure-Activity RelationshipAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2LipopolysaccharidesNitric OxideSesquiterpenesanti‐neuroinflammatorychloranthaceaelindenane sesquiterpenoid dimersSarcandra glabra

Identifiers

PMID41503792
PMCPMC13419919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.